ALB and chronic obstructive pulmonary disease: Second, by integrating markers of systemic inflammation (neutrophil-to-lymphocyte ratio) and nutritional status (BMI and serum albumin) into the ALI, the study offers a holistic approach to evaluating risk in COPD patients, moving beyond single-biomarker analyses.